GSK, RIOT among premarket gainers

|About: Aduro Biotech (ADRO)|By:, SA News Editor

Aduro BioTech (NASDAQ:ADRO) +21% on out-licenses cGAS-STING inhibitor program to Eli Lilly.

Riot Blockchain (NASDAQ:RIOT) +18%.

Winnebago Industries (NYSE:WGO) +10% on Q1 earnings.

Jabil (NYSE:JBL) +10% on Q1 earnings.

Adial Pharmaceuticals (NASDAQ:ADIL) +10% on amending its license agreement with the University of Virginia Patent Foundation.

Rent-A-Center (NASDAQ:RCII) +8% as B. Riley Financial issues statement.

Tilray (NASDAQ:TLRY) +5%.

GlaxoSmithKline plc (NYSE:GSK) +5% as Pfizer and Glaxo to merge consumer health unit.

Subscribe for full text news in your inbox